Literature DB >> 20546332

Endocrine tumours of the pancreas.

Caroline S Verbeke1.   

Abstract

Verbeke C S (2010) Histopathology 56, 669-682 Endocrine tumours of the pancreas Histopathology reporting of pancreatic endocrine neoplasms is complex. The tumours can exhibit a variety of morphological appearances, which often require careful differential diagnostic consideration. Prediction of tumour behaviour and clinical outcome is based on the World Health Organization classification and TNM staging and grading system, which share some criteria and premises, but differ significantly in others. Clinicopathological correlation through discussion at multidisciplinary team meetings is of paramount importance. In this review special emphasis is given to the items of information that can and should be provided by the pathologist to allow optimal patient management. The review further discusses areas of current controversy and uncertainty, of which pathologists participating in multidisciplinary discussions should be aware.

Entities:  

Mesh:

Year:  2010        PMID: 20546332     DOI: 10.1111/j.1365-2559.2010.03490.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.

Authors:  Chad M McCall; Chanjuan Shi; Toby C Cornish; David S Klimstra; Laura H Tang; Olca Basturk; Liew Jun Mun; Trevor A Ellison; Christopher L Wolfgang; Michael A Choti; Richard D Schulick; Barish H Edil; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

2.  Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.

Authors:  Satomi Kawamoto; Pamela T Johnson; Chanjuan Shi; Aatur D Singhi; Ralph H Hruban; Christopher L Wolfgang; Barish H Edil; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

3.  Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors:  R García-Carbonero; F Vilardell; P Jiménez-Fonseca; R González-Campora; E González; M Cuatrecasas; J Capdevila; I Aranda; J Barriuso; X Matías-Guiu
Journal:  Clin Transl Oncol       Date:  2013-06-08       Impact factor: 3.405

4.  Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement.

Authors:  Chad M McCall; Chanjuan Shi; Alison P Klein; Björn Konukiewitz; Barish H Edil; Trevor A Ellison; Christopher L Wolfgang; Richard D Schulick; Günter Klöppel; Ralph H Hruban
Journal:  Hum Pathol       Date:  2012-01-04       Impact factor: 3.466

5.  Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.

Authors:  Michelle D Reid; Pelin Bagci; Nobuyuki Ohike; Burcu Saka; Ipek Erbarut Seven; Nevra Dursun; Serdar Balci; Hasan Gucer; Kee-Taek Jang; Takuma Tajiri; Olca Basturk; So Yeon Kong; Michael Goodman; Gizem Akkas; Volkan Adsay
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

Review 6.  Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.

Authors:  Cynthia Ro; Wanxing Chai; Victoria E Yu; Run Yu
Journal:  Chin J Cancer       Date:  2012-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.